Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xenoport Inc (NASDAQ:XNPT)

7.01
Delayed Data
As of 4:00pm ET
 +0.02 / +0.29%
Today’s Change
3.35
Today|||52-Week Range
7.86
+27.69%
Year-to-Date
Biotech Stock Roundup: XenoPort Soars on Acquisition Deal, AbbVie Crohn's Disease Dru...
3:43pm / Zacks.com - Paid Partner Content
Xenoport's Cost-Cutting Tactics Lead to Buyout With Hefty Premium
May 23 / TheStreet.com - Paid Partner Content
Xenoport to be Acquired by Arbor Pharmaceuticals; Stock Up
May 24 / Zacks.com - Paid Partner Content
Here's Why XenoPort (XNPT) Stock is Continuing to Surge Today
May 23 / TheStreet.com - Paid Partner Content
Company News for May 24, 2016
May 24 / Zacks.com - Paid Partner Content
Why XenoPort, Inc. Is Skyrocketing 56.6% Today
May 23 / MotleyFool.com - Paid Partner Content
Benzinga's M&A Chatter for Monday May 23, 2016
May 23 / Benzinga - Paid Partner Content
Trending Tickers: XNPT, OLED, MON, TPUB
May 23 / TheStreet.com - Paid Partner Content
Why Monsanto, XenoPort, and LendingClub Jumped Today
May 23 / MotleyFool.com - Paid Partner Content
XenoPort (XNPT) Stock Skyrockets, Arbor Pharmaceuticals Acquiring For $467 Million
May 23 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close6.99
Today’s open6.96
Day’s range6.94 - 7.01
Volume3,374,105
Average volume (3 months)1,328,067
Market cap$444.1M
Dividend yield--
Data as of 4:00pm ET, 05/25/2016

Growth & Valuation

Earnings growth (last year)-60.49%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-12.18%
P/E ratioNM
Price/Sales8.43
Price/Book21.83

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp+0.30+2.67%
COCPCocrystal Pharma Inc-0.01-2.34%
RPTPRaptor Pharmaceutica...+0.04+0.78%
ENTAEnanta Pharmaceutica...-0.45-1.86%
Data as of 4:00pm ET, 05/25/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$41.2M
Annual profit (last year)-$82.3M
Net profit margin-199.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Vincent J. Angotti
Chief Financial Officer &
Senior VP-Finance
William G. Harris
Corporate headquarters
Santa Clara, California

Forecasts

Partner Offers

Search for Jobs